Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07073924 · ClinicalTrials.gov registry record · NA
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
A NA study, sponsored by University of Pittsburgh.
- Not yet
- Registry status
- NA
- Development phase
- 536
- Enrollment target
NCT07073924 is a NA study that has not yet begun recruiting, run by University of Pittsburgh. The registered enrollment target is 536 participants.
The verdict
NCT07073924, a NA study, has not yet begun recruiting, sponsored by University of Pittsburgh.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 536 participants
- Enrollment target
Study Summary
In the U.S., an estimated 3.6 million people who inject drugs (PWID) face a growing yet preventable health crisis, with rising cases of serious injection-related infections (SIRI), including HIV, due to limited access to two high-priority interventions: sterile injection equipment and daily oral HIV pre-exposure prophylaxis (PrEP). Outpatient clinics represent an opportune venue to implement these interventions. Yet most clinical providers in these settings do not currently provide them, contributing to a wide gap between evidence and routine practice. The Prescribe to Prevent HIV (P2PH) trial is a participatory study designed to co-develop and pilot test a set of implementation strategies to support outpatients clinics in offering sterile injection equipment and PrEP with the goal of reducing the risk of HIV and SIRI among PWID. This study is supported by the HEAL Initiative (https://heal.nih.gov/).
Interventions
- BEHAVIORAL Implementation strategy bundle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 536 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07073924
The ClinicalTrials.gov registry entry for NCT07073924 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 536 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implementation strategy bundle is the first listed.
NCT07073924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07073924 about?
NCT07073924 is a clinical study titled "Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support". In the U.S., an estimated 3.6 million people who inject drugs (PWID) face a growing yet preventable health crisis, with rising cases of serious injection-related infections (SIRI), including HIV, due to limited access to two high-priority interventions: sterile injection equipment and daily oral HIV...
What is the current status of trial NCT07073924?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 536 participants. The study started on 2026-08-01. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07073924?
The interventions under investigation include: Implementation strategy bundle (BEHAVIORAL).
Who is sponsoring clinical trial NCT07073924?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.